Bull Hedging
  • Politics
  • Stocks
  • Business
  • Investing
  • Politics
  • Stocks
  • Business
  • Investing

Bull Hedging

Politics

Fetterman says RFK Jr confirmation ‘not a slam dunk,’ as Trump HHS nominee shores up support

by admin February 3, 2025
February 3, 2025
Fetterman says RFK Jr confirmation ‘not a slam dunk,’ as Trump HHS nominee shores up support

Sen. John Fetterman, D-Pa., said the confirmation of Robert F. Kennedy Jr. to lead the Department of Health and Human Services is ‘not a slam dunk,’ as President Donald Trump’s nominee works to shore up support.

In an appearance on ‘Fox News Sunday,’ Fetterman said he has met with Kennedy twice in his office and that whatever his decision ends up being on the HHS nominee, it will be ‘an informed view.’ 

‘I’ve invested a lot of time to really understand his background and to learn more about the man,’ Fetterman said, adding: ‘I approached with an open mind and I watched the hearing. And that’s how the process works.’ 

Asked if he’s reached a decision on whether he’ll vote ‘yay’ or ‘nay’ for Kennedy, Fetterman said he has spoken to colleagues on both sides regarding the matter. 

‘It’s been challenging for sure. Absolutely. It’s certainly not a slam dunk for the nomination,’ Fetterman told ‘Fox News Sunday’ host Shannon Bream. 

‘I’ve made an investment to really understand and talk to all of the nominees, and I treated everyone with respect and I took the time to listen, and that’s been part of my commitment,’ he added.

Kennedy, a lifelong Democrat who switched his presidential campaign against Biden to run as an Independent before ultimately dropping from the race to back Trump, made it through back-to-back grillings by the Senate Finance Committee on Wednesday and the Health Committee on Thursday. He still faces crucial committee and full Senate confirmation votes in his mission to lead 18 powerful federal agencies that oversee the nation’s food and health.

Most of the tough questions and sparring over his stances on vaccines, abortion, Medicaid and other issues came from Democrats on the two committees, but Thursday’s hearing ended with the top Republican on the Health panel saying he was ‘struggling’ with Kennedy’s nomination.

‘Your past of undermining confidence in vaccines with unfounded or misleading arguments concerns me,’ Sen. Bill Cassidy, R-La., told the nominee.

The physician from Louisiana, who is a crucial vote and who has voiced concerns over Kennedy’s past stance on vaccines, asked whether Kennedy can ‘be trusted to support the best public health.’ The senator told Kennedy, who seeks to lead key health agencies like the Centers for Disease Control and Prevention, the Food and Drug Administration, the National Institutes of Health and the Centers for Medicare and Medicaid Services, that ‘you may be hearing from me over the weekend.’

Kennedy, whose outspoken views on the pharmaceutical and food industries have also sparked controversy, has said he aims to shift the focus of the agencies he would oversee toward promotion of a healthy lifestyle, including overhauling dietary guidelines, taking aim at ultra-processed foods and getting to the root causes of chronic diseases.

A strong pro-life advocate, Sen. Lindsey Graham, R-S.C., told ‘Fox News Sunday’ that he is supporting Kennedy despite the nominee’s past comments saying he supported codifying Roe v. Wade and abortion ‘even if it’s full term.’  

‘I am now OK to supporting RFK Jr. because I think during the course of the hearing he’s committed to a Republican pro-life agenda, President Trump’s pro-life agenda,’ Graham said when asked about those specific past remarks from Kennedy. ‘So I will take him at his word. I’m comfortable with what he said on the pro-life issue. He has been radically pro-choice as a person. But I do believe that as secretary, he will implement a pro-life agenda that will be pushed by President Trump. I will be a yes, but I’ll also watch every move he makes.’ 

Fox News’ Paul Steinhauser contributed to this report.

This post appeared first on FOX NEWS

previous post
JONATHAN TURLEY: End NPR’s taxpayer-funded gravy train
next post
Israel’s Netanyahu departs for US to meet with Trump, hoping to strengthen ties with Washington

Related Posts

GOP rep who returned to Congress after eight-year...

February 16, 2025

‘Important opportunity’: DNC chair candidates reveal how they...

February 1, 2025

Jill Biden should have to answer for ‘cover...

May 30, 2025

Trump admin steps up overhaul of National Security...

May 24, 2025

Trump announces MAHA advocate Casey Means will be...

May 8, 2025

SCOOP: House to hold hearings next week on...

March 25, 2025

Netanyahu goes against doctor’s orders, appears in Israeli...

January 1, 2025

First-term House Dem attacks White House spox Karoline...

January 30, 2025

Elon Musk warpath against Trump’s ‘big, beautiful bill’...

June 5, 2025

Lauren Sanchez tones down look after backlash for...

January 22, 2025

Recent Posts

  • Breakouts, Momentum & Moving Averages: 10 Must-See Stock Charts Right Now
  • Hedge Market Volatility with These Dividend Aristocrats & Sector Leaders
  • S&P 500 Bullish Patterns: Are Higher Highs Ahead?
  • Strategic Chaos or Tactical Goldmine? What QQQ’s Chart is Whispering Right Now
  • Why ADX Can Mislead You — And How to Avoid It

Recent Comments

No comments to show.

About Us

About Us

Design Magazine

Welcome to Design Magazine. Follow us for daily & updated design tips, guide and knowledge.

Stay Connect

Facebook Twitter Instagram Pinterest Youtube Email

Recent Posts

  • Breakouts, Momentum & Moving Averages: 10 Must-See Stock Charts Right Now

    June 5, 2025
  • Hedge Market Volatility with These Dividend Aristocrats & Sector Leaders

    June 5, 2025
  • S&P 500 Bullish Patterns: Are Higher Highs Ahead?

    June 5, 2025
  • Strategic Chaos or Tactical Goldmine? What QQQ’s Chart is Whispering Right Now

    June 5, 2025
  • Why ADX Can Mislead You — And How to Avoid It

    June 5, 2025
  • S&P 500 on the Verge of 6,000: What’s at Stake?

    June 5, 2025

Editors’ Picks

  • 1

    Small Caps are Set to Skyrocket in 2025—Here’s What You Need to Know

    December 12, 2024
  • 2

    Trump leaves China guessing what his next move is with unusual inauguration invitation

    December 15, 2024
  • 3

    Uranium Price Forecast: Top Trends That Will Affect Uranium in 2025

    December 19, 2024
  • 4

    Ad revenue should stabilize for media companies in 2025 — if they have sports

    December 31, 2024
  • 5

    Zinc Stocks: 4 Biggest Canadian Companies in 2025

    January 15, 2025
  • 6

    Trudeau declares himself ‘proud feminist’ after lamenting Harris loss to Trump as setback for women

    December 13, 2024
  • 7

    Lead Price Forecast: Top Trends for Lead in 2025

    January 11, 2025
Promotion Image

banner

Categories

  • Business (388)
  • Investing (1,273)
  • Politics (1,577)
  • Stocks (525)
  • About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: bullhedging.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2025 bullhedging.com | All Rights Reserved